Pharmacokinetics of intravenously administered isepamicin in men.

Antimicrobial Agents and Chemotherapy
C C LinM B Affrime

Abstract

The pharmacokinetics of isepamicin, a broad-spectrum aminoglycoside antibiotic, were studied in men after intravenous administration. Three groups of six volunteers received isepamicin for 10 consecutive days by 0.5-h intravenous infusions at respective dosages of 7.5 mg/kg of body weight once daily, 7.5 mg/kg twice daily, and 15 mg/kg once daily. Levels of isepamicin in plasma and urine were determined by a specific high-performance liquid chromatography method. For all three groups, steady-state concentrations of the drug in plasma were attained with the first dose. The area under the concentration-time curve for plasma and urinary drug excretion were dose proportional. A half-life ranging from 2.0 to 2.5 h was independent of the dosage regimen. Isepamicin excreted in urine over 24 h accounted for about 100% of the dose. The results show that the pharmacokinetics of isepamicin are linear with these dosage regimens. The drug does not accumulate upon multiple dosing, undergoes no detectable biotransformation, and is cleared solely by urinary excretion.

References

May 1, 1979·Clinical Pharmacokinetics·J C Pechere, R Dugal
May 1, 1978·Clinical Pharmacology and Therapeutics·J A JahreH C Neu
Jun 1, 1978·Clinical Pharmacology and Therapeutics·J C PechereM M Pechere
Apr 1, 1987·Antimicrobial Agents and Chemotherapy·N E WinsladeJ J Schentag
May 1, 1973·Clinical Pharmacology and Therapeutics·C RegameyW M Kirby
Nov 1, 1983·Clinical Pharmacology and Therapeutics·O L LaskinP S Lietman
Oct 1, 1981·Journal of Pharmacokinetics and Biopharmaceutics·M ChungS Symchowicz
Feb 1, 1980·Antimicrobial Agents and Chemotherapy·M ChungS Symchowicz
Oct 1, 1995·Antimicrobial Agents and Chemotherapy·C LinM N Cayen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.